Global Trisenox Market Professional Survey Report 2019
Trisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocytic leukae...
$3,500.00 04 October, 2019 | QYResearch
Global Trisenox Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Trisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocy...
Global Revcovi Market Professional Survey Report 2019
Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The global Revco...
$3,500.00 04 October, 2019 | QYResearch
Global Revcovi Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The gl...
Global Ebola Treatment Market Professional Survey Report 2019
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequ...
$3,500.00 04 October, 2019 | QYResearch
Global Ebola Treatment Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease w...
Global Multiple Sclerosis Therapeutics Market Professional Survey Report 2019
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protec...
$3,500.00 04 October, 2019 | QYResearch
Global Multiple Sclerosis Therapeutics Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks ...
Global Human Respiratory Syncytial Virus Drugs Market Professional Survey Report 2019
Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infect...
$3,500.00 04 October, 2019 | QYResearch
Global Human Respiratory Syncytial Virus Drugs Market Professional Survey Report 2019
$3,500.00 | 04 October, 2019 | QYResearch
Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tr...
Scope of the Report: The worldwide market for Denture Repair Material is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx ...
$3,480.00 07 October, 2019 | GIR (Global Info Research)
Global Denture Repair Material Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
$3,480.00 | 07 October, 2019 | GIR (Global Info Research)
Scope of the Report: The worldwide market for Denture Repair Material is expected to grow at a CAGR of roughly xx% over the next five years, will...
Scope of the Report: The worldwide market for Pulmonary Surfactant is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx mill...
$3,480.00 07 October, 2019 | GIR (Global Info Research)
Global Pulmonary Surfactant Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
$3,480.00 | 07 October, 2019 | GIR (Global Info Research)
Scope of the Report: The worldwide market for Pulmonary Surfactant is expected to grow at a CAGR of roughly xx% over the next five years, will rea...
The South Africa Central Nervous System (CNS) Therapeutic market is expected to reach US$ 3,686.91 Mn in 2027 from US$ 2,267.59 Mn in 2018. The market is est...
$3,000.00 07 October, 2019 | The Insight Partners
South Africa Central Nervous System (CNS) Therapeutic Market to 2027 - Regional Analysis and Forecasts by Disease Type (Neurovascular Diseases, Degenerative Disorders, Mental Health, Trauma, Others); Drug Type (Analgesics, Nervous System Drugs, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Geography
$3,000.00 | 07 October, 2019 | The Insight Partners
The South Africa Central Nervous System (CNS) Therapeutic market is expected to reach US$ 3,686.91 Mn in 2027 from US$ 2,267.59 Mn in 2018. The mar...
The South Africa anti-infective market is expected to reach US$ 2,572.5 Mn in 2027 from US$ 1,893.5 Mn in 2018. The market is estimated to grow with a CAGR o...
$3,000.00 07 October, 2019 | The Insight Partners
South Africa Anti-Infective Market to 2027 - Regional Analysis and Forecasts by Type (Antibacterial, Antiviral and Antifungal); Range (Broad Spectrum and Narrow Spectrum), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Mail Order Pharmacies)
$3,000.00 | 07 October, 2019 | The Insight Partners
The South Africa anti-infective market is expected to reach US$ 2,572.5 Mn in 2027 from US$ 1,893.5 Mn in 2018. The market is estimated to grow wit...
The global pre-clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.42 Mn in 2018. The pre-clinical CROs market is estimated to gr...
$4,550.00 07 October, 2019 | The Insight Partners
Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service (Bio-analysis & DMPK Studies, Toxicology, and Other Services); End User (Biopharmaceutical Companies, Government & Academic Institutes, and Medical Device Companies), and Geography
$4,550.00 | 07 October, 2019 | The Insight Partners
The global pre-clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.42 Mn in 2018. The pre-clinical CROs market is estim...